Return to home page
Searching: Muskingum library catalog
Some OPAL libraries remain closed or are operating at reduced service levels. Materials from those libraries may not be requestable; requested items may take longer to arrive. Note that pickup procedures may differ between libraries. Please contact your library for new procedures, specific requests, or other assistance.

LEADER 00000cam  2200601Ki 4500 
001    844975955 
003    OCoLC 
005    20181102031130.4 
006    m     o  d         
007    cr cnu---unuuu 
008    130529s2012    nyua    ob    001 0 eng d 
020    9781620818268|q(electronic bk.) 
020    1620818264|q(electronic bk.) 
020    |z9781620818138 
020    |z1620818132 
035    (OCoLC)844975955 
040    N$T|beng|epn|erda|cN$T|dE7B|dYDXCP|dOCLCF|dEBLCP|dOCLCQ
       |dD6H|dAGLDB|dOCLCQ|dVTS|dINT|dAU@ 
049    MAIN 
050  4 RM316 
072  7 MED|x105020|2bisacsh 
072  7 MED|x093000|2bisacsh 
082 04 615.78|223 
245 00 Synthetic drugs :|bscope and trends in synthetic 
       cannabinoids and stimulants /|cTerrence L. Gray and Sage 
       F. Evans, editors. 
264  1 Hauppauge, N.Y. :|bNova Science ;|aLancaster :|bGazelle 
       [distributor],|c2012. 
300    1 online resource (xi, 122 pages) :|billustrations. 
336    text|btxt|2rdacontent 
337    computer|bc|2rdamedia 
338    online resource|bcr|2rdacarrier 
340    |gpolychrome|2rdacc|0http://rdaregistry.info/termList/
       RDAColourContent/1003 
347    text file|2rdaft|0http://rdaregistry.info/termList/
       fileType/1002 
490 1  Substance abuse assessment, interventions and treatment 
490 1  Drug transit and distribution, interception and control 
504    Includes bibliographical references and index. 
505 0  SYNTHETIC DRUGS: SCOPE AND TRENDS IN SYNTHETIC 
       CANNABINOIDS AND STIMULANTS; SYNTHETIC DRUGS: SCOPE AND 
       TRENDS IN SYNTHETIC CANNABINOIDS AND STIMULANTS; Library 
       of Congress Cataloging-in-Publication Data; CONTENTS; 
       PREFACE; Chapter 1: SYNTHETIC DRUGS: OVERVIEW AND ISSUES 
       FOR CONGRESS; SUMMARY; BACKGROUND ON SYNTHETIC AND 
       DESIGNER DRUGS; SCHEDULING OF SYNTHETIC DRUGS: CONTROLLED 
       SUBSTANCES ACT; CURRENT TRENDS IN SELECTED SYNTHETICS; 
       SELECTED LEGISLATION IN THE 112TH CONGRESS; ISSUES; 
       Chapter 2: STATEMENT OF SENATOR DIANNE FEINSTEIN. HEARING 
       ON ''DANGEROUS SYNTHETIC DRUGS"" 
505 8  Chapter 3: STATEMENT OF SENATOR CHARLES GRASSLEY. HEARING 
       ON "DANGEROUS SYNTHETIC DRUGS"Chapter 4: STATEMENT OF 
       JOSEPH RANNAZZISI, DEA DEPUTY ASSISTANT ADMINISTRATOR. 
       HEARING ON "DANGEROUS SYNTHETIC DRUGS"; INTRODUCTION; 
       SITUATIONAL OVERVIEW; CURRENT EFFORTS AND CHALLENGES -- 
       TEMPORARY SCHEDULING AND PROSECUTION UNDER THE ANALOGUE 
       STATUTE; CONCLUSION; Chapter 5: STATEMENT OF ERICA LEARY, 
       PROGRAM MANAGER, NORTH COASTAL PREVENTION COALITION. 
       HEARING ON"DANGEROUS SYNTHETIC DRUGS"; THE IMPACT OF 
       SYNTHETIC MARIJUANA IN SAN DIEGO COUNTY; ACCESS, 
       AVAILABILITY, AND PROMOTION. 
505 8  EFFORTS UNDERTAKEN TO COMBAT THE PROBLEMHOW THE COMBATING 
       DANGEROUS DESIGNER DRUGS ACT OF 2011 WILL HELP 
       COMMUNITIES; WHY COMMUNITY COALITIONS ARE KEYS TO SUCCESS;
       Chapter 6: STATEMENT OF MIKE ROZGA. HEARING ON "DANGEROUS 
       SYNTHETIC DRUGS"; Chapter 7: AFFIDAVIT OF ANTHONY SCALZO, 
       MD. HEARING ON "DANGEROUS SYNTHETIC DRUGS"; Chapter 8: 
       SYNTHETIC CANNABINOIDS AND SYNTHETIC CATHINONES REPORTED 
       IN NFLIS, 2009-2010; HIGHLIGHTS; INTRODUCTION; NATIONAL 
       AND REGIONAL ESTIMATES; SYNTHETIC CANNABINOIDS AND 
       SYNTHETICCATHINONES, BY STATE IN NFLIS, 2010; NATIONAL 
       POISON CONTROL CENTER DATA. 
505 8  APPENDIX. CHEMICAL NAMES OF SYNTHETIC CANNABINOIDS AND 
       SYNTHETIC CATHINONESChapter 9: NIDA INFOFACTS: SPICE; HOW 
       IS SPICE ABUSED?; EXTENT OF USE; WHAT ARE THE HEALTH 
       EFFECTS OF SPICE ABUSE?; OTHER INFORMATION SOURCES; 
       RESOURCES; Chapter 10: JWH-018 1-PENTYL-3-(1-NAPHTHOYL) 
       INDOLE [SYNTHETIC CANNABINOID IN HERBAL PRODUCTS]; 
       INTRODUCTION; LICIT USES; CHEMISTRY; PHARMACOLOGY; ILLICIT
       USES; USER POPULATION; ILLICIT DISTRIBUTION; CONTROL 
       STATUS; Chapter 11: JWH-073 1-BUTYL-3-(1-NAPHTHOYL) INDOLE
       [SYNTHETIC CANNABINOID IN HERBAL PRODUCTS]; INTRODUCTION; 
       LICIT USES; CHEMISTRY; PHARMACOLOGY. 
505 8  ILLICIT USESUSER POPULATION; ILLICIT DISTRIBUTION; CONTROL
       STATUS; Chapter 12: 3,4-METHYLENEDIOXYPYROVALERONE (MDPV);
       INTRODUCTION; LICIT USES; CHEMISTRY; PHARMACOLOGY; USER 
       POPULATION; ILLICIT DISTRIBUTION; CONTROL STATUS; Chapter 
       13: NIDA INFOFACTS: METHAMPHETAMINE; HOW IS 
       METHAMPHETAMINE ABUSED?; HOW DOES METHAMPHETAMINE AFFECT 
       THE BRAIN?; WHAT OTHER ADVERSE EFFECTS DOES 
       METHAMPHETAMINE HAVE ON HEALTH?; WHAT TREATMENT OPTIONS 
       EXIST?; HOW WIDESPREAD IS METHAMPHETAMINE ABUSE?; OTHER 
       INFORMATION SOURCES; REFERENCES; Chapter 14: NIDA 
       INFOFACTS: MDMA (ECSTASY); HOW IS MDMA ABUSED? 
588 0  Print version record. 
650  0 Designer drugs.|0http://id.loc.gov/authorities/subjects/
       sh86006022 
655  4 Electronic books. 
700 1  Gray, Terrence L. 
700 1  Evans, Sage F. 
776 08 |iPrint version:|tSynthetic drugs.|dHauppauge, N.Y. : Nova
       Science ; Lancaster : Gazelle [distributor], 2012
       |z9781620818138|w(OCoLC)834070198 
830  0 Substance abuse assessment, interventions and treatment. 
830  0 Drug transit and distribution, interception and control.
       |0http://id.loc.gov/authorities/names/no2009139441 
956 40 |uhttp://proxy.opal-libraries.org/login?url=http://
       search.ebscohost.com/login.aspx?direct=true&scope=site&
       db=nlebk&AN=581786|zView online 
990    eBooks on EBSCOhost|bEBSCO eBook Subscription Academic 
       Collection - North America|c2018-11-02|yMaster record 
       variable field(s) change: 505|5OHN 
990    eBooks on EBSCOhost|bEBSCO eBook Subscription Academic 
       Collection - North America|c2016-09-16|yMaster record 
       variable field(s) change: 245 

If you experience difficulty accessing or navigating this content, please contact the OPAL Support Team